RDIF to sell 32 million doses of coronavirus vaccine to Mexican pharmaceutical company – source

RDIF to sell 32 million doses of coronavirus vaccine to Mexican pharmaceutical company – source

RDIF to sell 32 million doses of coronavirus vaccine to Mexican pharmaceutical company - source

MOSCOW (Reuters) – The Russian Direct Investment Fund (RDIF) will sell 32 million doses of Sputnik V coronavirus vaccine to one of Mexico's leading pharmaceutical companies, a source close to the deal said Wednesday.

This is the second agreement for Russia to export COVID-19 vaccine.

The Sputnik V vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology, was registered in August. Post-registration tests, in which 40,000 volunteers are to take part, began on August 26.

Kazakhstan in August signed an agreement with RDIF to supply over 2 million doses of a potential vaccine after passing all tests. The country can increase its supply to 5 million doses.

The source said the deal with Mexico could be announced later Wednesday.

(Polina Ivanova. Translated by Vladimir Sadykov. Editor Marina Bobrova)

Leave a Reply

Your email address will not be published. Required fields are marked *